Solventum Corp

SOLV NYSE CIK: 0001964738

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 1750 YANKEE DOODLE ROAD, EAGAN, MN, 55121
Mailing Address 1750 YANKEE DOODLE ROAD, EAGAN, MN, 55121
Phone 651-733-1110
Fiscal Year End 1231
EIN 922008841

Financial Overview

FY2025

$14.46B
Total Assets
$11.50B
Total Liabilities
$878.00M
Cash & Equivalents
$8.94
EPS

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 30, 2026 View on SEC
4 Insider stock transaction report March 30, 2026 View on SEC
4 Insider stock transaction report March 30, 2026 View on SEC
4 Insider stock transaction report March 30, 2026 View on SEC
4 Insider stock transaction report March 30, 2026 View on SEC
4 Insider stock transaction report March 30, 2026 View on SEC
4 Insider stock transaction report March 30, 2026 View on SEC
4 Insider stock transaction report March 30, 2026 View on SEC
4 Insider stock transaction report March 30, 2026 View on SEC
4 Insider stock transaction report March 30, 2026 View on SEC

Annual Reports

10-K February 27, 2026
  • Increased operating profit by 9.1% to $1.2 billion in 2025 despite a 1.6% sales dip, showcasing strong cost management and operational efficiency.
  • Strategic acquisition of Acera Surgical for $150 million, expanding the MedSurg portfolio with innovative biologic skin substitute technologies.
View Analysis

Material Events

8-K Strategy Change December 16, 2025
High Impact
  • Solventum Corp issued a letter to shareholders detailing significant progress in its first year as a standalone public company.
  • The company launched a long-range plan, achieved six consecutive quarters of positive sales growth, and raised its financial outlook.
View Analysis

Insider Trading

BUY 1 insiders 1 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.